End Points in Studies on the Prevention of Deep Vein Thrombosis

 

 Buy Article Permissions and Reprints

ABSTRACT

Clinically overt events are of obvious relevance for the outcome of patients. There is unanimous consensus of clinicians that these events should be prevented in clinical practice. In clinical trials on the prevention of deep vein thrombosis, symptomatic objectively confirmed venous thromboembolism is the most important outcome to be measured. However, because of the difficulties related to the measurement of clinically overt events, venography is the most commonly used method for end-point measurement in clinical trials on the prevention of venous thromboembolism. The limitations of venography leave a great need for the development of accurate noninvasive methods to be used as alternatives to venography. The end point must be tailored to the phase of the clinical trial. In phase I/II clinical trials, that are designed to evaluate the effectiveness of thromboprophylactic agents, it still is necessary to use the most accurate method for the diagnosis of deep vein thrombosis and to perform bilateral venography. When a new pharmacologic agent is compared with the ``gold standard'' agent, the use of symptomatic end points should be preferable.

REFERENCES

• 1 Lea Thomas M. Phlebography.  Arch Surg . 1972;  104 145-151
  PubMedGoogle Scholar
• 2 Rabinov K, Paulin S. Roengten diagnosis of venous thrombosis in the leg.  Arch Surg . 1972;  104 134-144
  PubMedGoogle Scholar
• 3 Lensing AWA,Hirsh J, Büller H. Diagnosis of venous thrombosis. In: Colman RW, Hirsh J, Marder VJ and Salzman JB; eds. Hemostasis and Thrombosis Basic Principles and Clinical Practice, 3rd ed Philadelphia: JB Lippincott Company, 1994: 1297-1321
  Google Scholar
• 4 Kälebo P, Ekman S, Lindbratt S. Percentage of inadequate phlebograms and observer agreement in thromboprophylactic multicenter trials using standardized methodology and central assessment.  Thromb Haemost . 1996;  76 893-896
  PubMedGoogle Scholar
• 5 Eriksson B I, Ekman S, Kälebo P. Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393.  Lancet . 1996;  347 635-639
  CrossrefPubMedGoogle Scholar
• 6 Eriksson B I, Ekman S, Lindbratt S. Prevention of thromboembolism with use of recombinant hirudin: results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement.  J Bone Joint Surg A . 1997;  79 326-333
  PubMedGoogle Scholar
• 7 Landis J R, Koch G G. The measurements of observer agreement for categorial data.  Biometrics . 1977;  33 159-174
  CrossrefPubMedGoogle Scholar
• 8 Rossi R, Agnelli G, Taborelli P. Local versus central assessment of venographies in a multicenter trial on the prevention of deep vein thrombosis in neurosurgery.  Thromb Haemost . 1999;  82 1399-1402
  PubMedGoogle Scholar
• 9 Agnelli G, Piovella F, Buoncristiani P. Enoxaparin plus compression stockings versus compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.  N Engl J Med . 1998;  339 80-85
  CrossrefPubMedGoogle Scholar
• 10 Planes A, Vochelle N, Karmon J Y. Risk of deep-vein thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomized comparison of enoxaparin versus placebo.  Lancet . 1996;  348 224-228
  CrossrefPubMedGoogle Scholar
• 11 Bergqvist D, Benoni G, Björgell O. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement.  N Engl J Med . 1996;  335 696-700
  CrossrefPubMedGoogle Scholar
• 12 Dahl O E, Andreassen G, Aspelin T. Prolonged thromboprophylaxis following hip replacement surgery-results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin^℗).  Thromb Haemost . 1997;  77 26-31
  PubMedGoogle Scholar
• 13 Lassen M R, Borris L C, Anderson B S. Efficacy and safety of prolonged thromboprophylaxis with low molecular weight heparin (dalteparin) after total hip arthroplasty-the Danish Prolonged Prophylaxis (DaPP) study.  Thromb Res . 1998;  15 281-288
  PubMedGoogle Scholar
• 14 Cruickshank M K, Levine M N, Hirsh J. An evaluation of impedance plethysmography and ¹²⁵I fibrinogen leg scanning in patients following hip surgery.Thromb Haemost .  1989;  62 830-834
  PubMedGoogle Scholar
• 15 Agnelli G, Cosmi B, Ranucci V. Impedance plethysmography in the diagnosis of asymptomatic deep vein thrombosis in hip surgery. A venography-controlled study.  Arch Intern Med . 1991;  151 2167-2171
  CrossrefPubMedGoogle Scholar
• 16 Lensing A WA, Hirsh J. ¹²⁵I Fibrinogen leg scanning: reassessment of its role for the diagnosis of venous thrombosis in post-operative patients.  Thromb Haemost . 1993;  69 2-7
  PubMedGoogle Scholar
• 17 Wells P S, Lensing A W, Davidson B L, Prins M H, Hirsh J. Accuracy of ultrasound for the diagnosis of deep vein thrombosis in asymptomatic patients after orthopedic surgery. A meta-analysis.  Ann Intern Med . 1995;  122 47-53
  PubMedGoogle Scholar
• 18 Lensing A W, Doris C I, Mc Grath P F. A comparison of compression ultrasound with color-Doppler ultrasound for the diagnosis of symptomless post-operative deep vein thrombosis.  Arch Intern Med . 1997;  127 439-445
  PubMedGoogle Scholar
• 19 Douglas J T, Blamey S L, Lowe G D, Carter D C, Forbes C D. Plasma beta-thromboglobulin, fibrinopeptide A and B beta 15-42 antigen in relation to post-operative DVT, malignancy and stanozol treatment.  Thromb Haemost . 1985;  53 235-238
  PubMedGoogle Scholar
• 20 Hoek J A, Nurmohamed M T, ten Cate W J. Thrombin-antithrombin III complexes in the prediction of deep vein thrombosis following total hip replacement.  Thromb Haemost . 1989;  62 1050-1052
  PubMedGoogle Scholar
• 21 Jørgensen L N, Lind B, Hauch O. Thrombin-antithrombin complex and fibrin-degradation products in plasma: surgery and post-operative deep venous thrombosis.  Thromb Res . 1990;  59 69-76
  CrossrefPubMedGoogle Scholar
• 22 The Venous Thrombosis Group. The value of Enzygnost TAT test in the diagnosis of post-operative deep vein thrombosis after hip surgery.  Thromb Res . 1989;  54 505-509
  CrossrefPubMedGoogle Scholar
• 23 Bounameaux H, Khabiri E, Huber O. Value of liquid crystal contact thermography and plasma level of D-dimer for screening of deep vein thrombosis following general abdominal surgery.  Thromb Haemost . 1992;  67 603-606
  PubMedGoogle Scholar
• 24 Rowbotham B J, Whitaker A N, Harrison J. Measurement of cross-linked fibrin derivatives in patients undergoing abdominal surgery: use in the diagnosis of post-operative venous thrombosis.  Blood Coagul Fibrinolysis . 1992;  3 25-31
  PubMedGoogle Scholar
• 25 Dunn I D, Hui A CW, Triffitt P D. Plasma D-dimer as a marker for post-operative deep vein thrombosis. A study after total hip or knee arthroplasty.  Thromb Haemost . 1994;  72 663-665
  PubMedGoogle Scholar
• 26 Bongard O, Wicky J, Peter R. D-dimer plasma measurement in patients undergoing major hip surgery: use in the prediction and diagnosis of postoperative proximal deep vein thrombosis.  Thromb Res . 1994;  74 487-493
  CrossrefPubMedGoogle Scholar
• 27 Cofrancesco E, Cortellaro M, Corradi A, Ravasi F, Bertocchi F. Clinical utility of prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimer measurement in the diagnosis of deep vein thrombosis following total hip replacement.  Thromb Haemost . 1998;  79 509-510
  PubMedGoogle Scholar
• 28 Bounameaux H, Miron M-J, Blanchard J. Measurement of plasma D-Dimer is not useful in the prediction or diagnosis of postoperative deep vein thrombosis in patients undergoing total knee arthroplasty.  Blood Coagul Fibrinolysis . 1998;  9 749-752
  CrossrefPubMedGoogle Scholar
• 29 Bara L, Planes A, Samama M M. Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti II activities, and D-Dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery.  Br J Haematol . 1999;  104 230-240
  PubMedGoogle Scholar
• 30 Ricotta S, Iorio A, Parise P, Nenci G G, Agnelli G. Post discharge clinically overt venous thromboembolism in orthopaedic surgery patients with negative venography. An overview analysis.  Thromb Haemost . 1996;  76 887-892
  PubMedGoogle Scholar
• 31 Warwick D, Williams M H, Bannister G C. Death and thromboembolic disease after total hip replacement.  J Bone Joint Surg B . 1995;  77 6-10
  PubMedGoogle Scholar
• 32 Khaw F M, Moran C G, Pinder I M, Smith S R. The incidence of fatal pulmonary embolism after knee replacement with no prophylactic anticoagulation.  J Bone Joint Surg B . 1993;  75 940-941
  PubMedGoogle Scholar
• 33 Colwell Jr W C, Collis D K, Paulson R. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge.  J Bone Joint Surg A . 1999;  81 932-940
  PubMedGoogle Scholar